{
    "clinical_study": {
        "@rank": "147841", 
        "acronym": "CABERNET", 
        "arm_group": [
            {
                "arm_group_label": "balloon sinus dilation", 
                "arm_group_type": "Active Comparator", 
                "description": "Balloon sinus dilation will be conducted in-office under local anesthesia."
            }, 
            {
                "arm_group_label": "medical therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Medical therapy as needed per subject's specific disease and as determined by the investigators' clinical judgment."
            }
        ], 
        "brief_summary": {
            "textblock": "This post-market study aims to compare health outcomes for Recurrent Acute Rhinosinusitis\n      (RARS) patients treated with balloon sinus dilation (BSD) versus medical management alone."
        }, 
        "brief_title": "Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients (CABERNET)", 
        "completion_date": {
            "#text": "January 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Recurrent Acute Rhinosinusitis", 
        "condition_browse": {
            "mesh_term": "Sinusitis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  19 years of age or greater\n\n          -  diagnosis of recurrent acute rhinosinusitis\n\n          -  suitable candidate for office-based procedure\n\n          -  willing and able to read and sign informed consent and remain compliant with protocol\n             and study procedures\n\n          -  able to read and understand English\n\n        Exclusion Criteria:\n\n          -  diagnosis of chronic rhinosinusitis\n\n          -  prior sinus surgery\n\n          -  physician determined need for ancillary procedures\n\n          -  known immune deficiency, ciliary dysfunction and/or autoimmune disease\n\n          -  clinically significant illness that may interfere with evaluation of the study\n\n          -  participation in clinical studies 6 months prior to study participation\n\n          -  pregnant or lactating females"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "19 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 24, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01714687", 
            "org_study_id": "CPR005030"
        }, 
        "intervention": [
            {
                "arm_group_label": "balloon sinus dilation", 
                "intervention_name": "balloon sinus dilation", 
                "intervention_type": "Device", 
                "other_name": "balloon sinuplasty"
            }, 
            {
                "arm_group_label": [
                    "balloon sinus dilation", 
                    "medical therapy"
                ], 
                "intervention_name": "medical therapy", 
                "intervention_type": "Other", 
                "other_name": "medical management"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "March 12, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35242"
                    }, 
                    "name": "Alabama Nasal and Sinus Center"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30342"
                    }, 
                    "name": "ENT of Georgia"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89113"
                    }, 
                    "name": "Ear Nose and Throat Consultants of Nevada"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "McKinney", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75070"
                    }, 
                    "name": "ENT Associates of Texas"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Comparison of Balloon Sinuplasty In-Office Versus Medical Management for Recurrent Acute Sinusitis Patients: A Randomized Controlled Study (CABERNET)", 
        "overall_contact": {
            "email": "lenglan1@its.jnj.com", 
            "last_name": "England"
        }, 
        "overall_official": [
            {
                "affiliation": "Ear Nose and Throat Consultants of Nevada", 
                "last_name": "Ashley Sikand, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Alabama Nasal and Sinus Center", 
                "last_name": "Michael Sillers, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in disease-specific patient-reported quality of life (QOL)", 
            "safety_issue": "No", 
            "time_frame": "24 weeks post treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01714687"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change in disease-specific patient-reported quality of life", 
                "safety_issue": "No", 
                "time_frame": "24 and 48 weeks post treatment"
            }, 
            {
                "measure": "Change in disease-specific and general health-related quality of life", 
                "safety_issue": "No", 
                "time_frame": "8, 24 and 48 weeks post treatment"
            }, 
            {
                "measure": "Change in disease-specific medication usage", 
                "safety_issue": "No", 
                "time_frame": "24 and 48 weeks post treatment"
            }, 
            {
                "measure": "Missed days work/school and medical care visits due to sinusitis", 
                "safety_issue": "No", 
                "time_frame": "24 and 48 weeks post treatment"
            }, 
            {
                "measure": "Number of sinus infections", 
                "safety_issue": "No", 
                "time_frame": "48 weeks post treatment"
            }, 
            {
                "measure": "Number of subjects electing procedure (cross-over)", 
                "safety_issue": "No", 
                "time_frame": "48 weeks post treatment"
            }, 
            {
                "measure": "Post-procedure return to normal activity (RTNA)", 
                "safety_issue": "No", 
                "time_frame": "2 weeks post treatment"
            }
        ], 
        "source": "Acclarent", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Acclarent", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}